A citation-based method for searching scientific literature

Marc D Schwartz, Beth N Peshkin, Kenneth P Tercyak, Kathryn L Taylor, Heiddis Valdimarsdottir. Health Psychol 2005
Times Cited: 47







List of co-cited articles
259 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
19

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
17

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
17

Validation of a decisional conflict scale.
A M O'Connor. Med Decis Making 1995
14

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
72
14

Affect, risk, and decision making.
Paul Slovic, Ellen Peters, Melissa L Finucane, Donald G Macgregor. Health Psychol 2005
286
12

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
87
12

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004
189
10

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
10

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.
B Meiser, P Butow, M Friedlander, V Schnieden, M Gattas, J Kirk, G Suthers, E Haan, K Tucker. J Clin Oncol 2000
90
10

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Br J Cancer 2004
54
10

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment.
S van Dijk, W Otten, M W Zoeteweij, D R M Timmermans, C J van Asperen, M H Breuning, R A E M Tollenaar, J Kievit. Br J Cancer 2003
55
10

Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers.
Elizabeth M Kaufman, Beth N Peshkin, William F Lawrence, Rebecca Shelby, Claudine Isaacs, Karen Brown, Jessica Rispoli, Suzanne O'Neill, Karen Hurley, Tiffani DeMarco,[...]. J Genet Couns 2003
24
20

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process.
Glyn Elwyn, Annette O'Connor, Dawn Stacey, Robert Volk, Adrian Edwards, Angela Coulter, Richard Thomson, Alexandra Barratt, Michael Barry, Steven Bernstein,[...]. BMJ 2006
10

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
K A Metcalfe, A Poll, A O'Connor, S Gershman, S Armel, A Finch, R Demsky, B Rosen, S A Narod. Clin Genet 2007
51
10

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
10

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
10

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
155
10



Testing participation in BRCA1/2-positive families: initiator role of index cases.
Cécile Blandy, Françoise Chabal, Dominique Stoppa-Lyonnet, Claire Julian-Reynier. Genet Test 2003
44
11


Misimagining the unimaginable: the disability paradox and health care decision making.
Peter A Ubel, George Loewenstein, Norbert Schwarz, Dylan Smith. Health Psychol 2005
155
8

Risk as feelings.
G F Loewenstein, E U Weber, C K Hsee, N Welch. Psychol Bull 2001
8


Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
345
8

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
191
8

The Brief Symptom Inventory: an introductory report.
L R Derogatis, N Melisaratos. Psychol Med 1983
8

Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer.
K E Hurley, S M Miller, J W Costalas, D Gillespie, M B Daly. J Womens Health Gend Based Med 2001
32
12

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
598
8

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
8

Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.
Suzanne M Miller, Pagona Roussi, Mary B Daly, Joanne S Buzaglo, Kerry Sherman, Andrew K Godwin, Andrew Balshem, Margaret E Atchison. Health Educ Behav 2005
31
12

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
Catharine Wang, Richard Gonzalez, Kara J Milliron, Victor J Strecher, Sofia D Merajver. Am J Med Genet A 2005
54
8

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Jeffrey R Botkin, Ken R Smith, Robert T Croyle, Bonnie J Baty, Jean E Wylie, Debra Dutson, Anna Chan, Heidi A Hamann, Caryn Lerman, Jamie McDonald,[...]. Am J Med Genet A 2003
154
8

Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications.
A M O'Connor, V Fiset, C DeGrasse, I D Graham, W Evans, D Stacey, A Laupacis, P Tugwell. J Natl Cancer Inst Monogr 1999
163
8

Communicating genetic test results to the family: a six-step, skills-building strategy.
M B Daly, A Barsevick, S M Miller, R Buckman, J Costalas, S Montgomery, R Bingler. Fam Community Health 2001
59
8


Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
158
8


Advance directives and cancer decision making near the end of life.
Peter H Ditto, Nikki A Hawkins. Health Psychol 2005
41
7

Hot-cold empathy gaps and medical decision making.
George Loewenstein. Health Psychol 2005
139
6

Patients' values and clinical substituted judgments: the case of localized prostate cancer.
Arthur S Elstein, Gretchen B Chapman, Sara J Knight. Health Psychol 2005
33
9

A contextual approach to treatment decision making among breast cancer survivors.
Tracey A Revenson, Julie R Pranikoff. Health Psychol 2005
35
8

Decision making as coping.
Mary Frances Luce. Health Psychol 2005
39
7

Regret in cancer-related decisions.
Terry Connolly, Jochen Reb. Health Psychol 2005
85
6

Making better decisions: from measuring to constructing preferences.
Eric J Johnson, Mary Steffel, Daniel G Goldstein. Health Psychol 2005
29
10


Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, Claudine Isaacs, Chanita Hughes, Tiffani DeMarco, Clinton Finch, Caryn Lerman. J Clin Oncol 2003
95
6

What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
James C Coyne, Linda Kruus, Melissa Racioppo, Kathleen A Calzone, Katrina Armstrong. Am J Med Genet A 2003
43
6

Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
Chanita Hughes Halbert, Marc D Schwartz, Lari Wenzel, Steven Narod, Beth N Peshkin, David Cella, Caryn Lerman. J Behav Med 2004
27
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.